Financhill
Back

TransMedics Group Quote, Financials, Valuation and Earnings

TransMedics Group Price Quote

$75.21
-0.38 (-0.5%)
(Updated: March 22, 2023 at 3:50 PM ET)

TransMedics Group Key Stats

Buy
60
TransMedics Group (TMDX) is a Buy

Day range:
$74.38 - $77.00
52-week range:
$20.36 - $83.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
23.90
P/B ratio:
12.99%

Volume:
335.8K
Avg. volume:
546.5K
1-year change:
226.66%
Market cap:
$2.4B
Revenue:
$93.5M
EPS:
$-1.25

How Much Does TransMedics Group Make?

Is TransMedics Group Growing As A Company?

  • What Is TransMedics Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 2.25%
  • What Is TransMedics Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TransMedics Group Stock Price Performance

What Is TransMedics Group 52-Week High & Low?

TransMedics Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TransMedics Group?

  • How Much Debt Does TransMedics Group Have?
    Total long term debt quarterly is $58.7M
  • How Much Cash Does TransMedics Group Have?
    Cash and short term investments quarterly total is $201.2M
  • What Is TransMedics Group’s Book Value Per Share?
    Book value per share is 5.83

Is TransMedics Group Cash Flow Positive?

  • What Is TMDX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$45.8M
  • What Is TransMedics Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $167.9M
  • What Is TransMedics Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $54.5M

TransMedics Group Return On Invested Capital

  • Is Management Doing A Good Job?
    TMDX return on invested capital is -23.31%
  • What Is TransMedics Group Return On Assets?
    ROA measures how assets are converting to revenues and is -19.52%
  • What Is TMDX Return On Equity?
    ROE is a measure of profitability and is -32.71%

TransMedics Group Earnings Date & Stock Price

TransMedics Group Competitors

TransMedics Group Dividend Yield

Data Unavailable

TransMedics Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 23.63%
Revenue: 224.52% 32.92%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 78.60
Upside from Last Price: 3.98%

Major Shareholders

  • How many TMDX shares are owned by institutional investors?
    49.7M TMDX shares are owned by institutional investors
  • How many TMDX shares are owned by insiders?
    820.3K TMDX shares are owned by insiders